NVLPF (Nova Leap Health) 3-Year RORE % : 77.78% (As of Mar. 2026)


NVLPF Nova Leap Health Corp NVLPF
50 GF Score
Price $0.25
GF Value $0.18
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Nova Leap Health 3-Year RORE %?

Nova Leap Health NVLPF 50 3-Year RORE % is 77.78 as of Mar. 2026. GuruFocus rates NVLPF with a GF Score™ of 50/100 and a GF Value™ of $0.18 (Fairly Valued). The stock has 4 warning signs investors should review. Among 606 Healthcare Providers & Services companies, Nova Leap Health ranks better than 90.1% on this metric.

Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments. Nova Leap Health's 3-Year RORE % for the quarter that ended in Mar. 2026 was 77.78%.

The industry rank for Nova Leap Health's 3-Year RORE % or its related term are showing as below:

NVLPF's 3-Year RORE % is ranked better than
90.1% of 606 companies
in the Healthcare Providers & Services industry
Industry Median: 0.195 vs NVLPF: 77.78

Nova Leap Health  (OTCPK:NVLPF) 3-Year RORE % Explanation

Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.

There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.

Be Aware

Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.


Nova Leap Health 3-Year RORE % Related Terms


Nova Leap Health 3-Year RORE % Historical Data

* Premium members only.

The historical data trend for Nova Leap Health's 3-Year RORE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nova Leap Health 3-Year RORE % Chart

Nova Leap Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
3-Year RORE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 318.75 -100.00 1,600.00 -433.33 500.00

Nova Leap Health Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
3-Year RORE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -900.00 -137.50 -210.00 500.00 77.78

NVLPF vs HCA, THC, DVA: 3-Year RORE % Comparison

For the Medical Care Facilities subindustry, Nova Leap Health's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nova Leap Health 3-Year RORE % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Nova Leap Health's 3-Year RORE % distribution charts can be found below:

* The bar in red indicates where Nova Leap Health's 3-Year RORE % falls into.


NVLPF
50GF Score
Nova Leap Health Corp NVLPF
3-Year RORE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nova Leap Health 3-Year RORE % Calculation

Nova Leap Health's 3-Year RORE % for the quarter that ended in Mar. 2026 is calculated as:

3-Year RORE %=( Most Recent EPS (Diluted)- First Period EPS (Diluted) )/( Cumulative EPS (Diluted) for 3-year -Cumulative Dividends per Share for 3-year )
=( 0.003--0.004 )/( 0.009-0 )
=0.007/0.009
=77.78 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Mar. 2026 and 3-year before.

Frequently Asked Questions Learn more about 3-Year RORE % →
What does a 3-Year RORE % of 77.78 mean?
Nova Leap Health (NVLPF) has a 3-Year RORE % of 77.78 as of Mar. 2026. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Nova Leap Health and its competitors. According to the industry distribution chart, Nova Leap Health ranks #60 out of 606 companies in the Healthcare Providers & Services industry, placing it in the top 9.9%.
Is Nova Leap Health's 3-Year RORE % too high?
Nova Leap Health's current 3-Year RORE % is 77.78. The Healthcare Providers & Services industry median 3-Year RORE % is 0.20. Nova Leap Health's value of 77.78 is 39787.2% above this industry median. Based on the distribution chart, Nova Leap Health ranks #60 out of 606 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Nova Leap Health has a GF Score™ of 50/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Nova Leap Health's 3-Year RORE % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Nova Leap Health ranks #60 out of 606 companies for 3-Year RORE %. This places Nova Leap Health in the top 10% of its industry — outperforming the majority of peers. The industry median 3-Year RORE % is 0.20. Nova Leap Health's value of 77.78 is 39787.2% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year RORE % for a Healthcare Providers & Services company?
The median 3-Year RORE % among Healthcare Providers & Services companies is 0.20, based on 606 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year RORE % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year RORE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nova Leap Health's current 3-Year RORE % of 77.78 is 39787.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year RORE % mean?
A high 3-Year RORE % can signal that a stock is expensive relative to its fundamentals. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Nova Leap Health and its competitors. For the Healthcare Providers & Services industry, the median 3-Year RORE % is 0.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nova Leap Health's current 3-Year RORE % is 77.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nova Leap Health stock overvalued right now?
Based on GuruFocus' analysis, Nova Leap Health (NVLPF) is currently considered Fairly Valued. The stock's GF Value™ is $0.18, compared to a current price of $0.25 — trading 36.9% above its estimated fair value. The current 3-Year RORE % is 77.78 and 39787.2% above the Healthcare Providers & Services industry median of 0.20. Nova Leap Health's overall GF Score™ is 50/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year RORE % calculated?
3-Year RORE % is calculated from a company's financial statements. For Nova Leap Health (NVLPF), the current 3-Year RORE % is 77.78 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Nova Leap Health (NVLPF) Overvalued in 2026?

Based on GuruFocus' analysis, Nova Leap Health stock appears to be overvalued. The current stock price of $0.25 is trading 36.9% above its estimated GF Value™ of $0.18. GuruFocus considers Nova Leap Health to be Fairly Valued.

Key valuation signals for NVLPF:

  • 3-Year RORE %: 77.78
  • GF Value™: $0.18 vs. price of $0.25 (36.9% above fair value)
  • GF Score™: 50/100 with 4 warning signs
  • Industry Position: 39787.2% above the Healthcare Providers & Services median (#60 of 606)

No single metric tells the full story. See the NVLPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Nova Leap Health Business Description

Other Exchanges NLH:Canada
Address 7071 Bayers Road, Suite 3006, Halifax, NS, CAN, B3L 2C2
Nova Leap Health Corp operates in the healthcare industry. The company is a provider of home and home health care services to clients..The principal business activities of the company and its subsidiaries are to provide skilled and non-medical home care to clients. Its service offerings include meal preparation, housekeeping, transportation, personal care, and medication reminders. Its segments comprise Canadian and U.S. operations. The company derives a majority of its revenue from the United States.
50GF Score

Get the complete analysis for NVLPF

3-Year RORE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.25
Price
$0.18
GF Value